All News

Pembrolizumab was associated with clinically meaningful improvements in quality of life over chemotherapy.

Mylan pledges to manufacture affordable drugs in the midst of price-fixing allegations.

Researchers discovered a statistically significant link between diabetes and all-cause mortality.

Anti-inflammatory drugs suppress PGE2 production and leads to adverse events from peripheral blood hematopoietic stem cell harvesting.

Integrase inhibitors can reduce the HIV viral load to decrease transmission of the disease.

Integrase inhibitors reduce HIV viral load in the blood and semen.

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.

A new vaccine prevents euphoria associated with opioids.

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

ICER seeks comment on the effectiveness and value of disease modifying therapies for relapsing remitting and primary progressive multiple sclerosis.

Global HIV incidence rates drop in some African countries.

FDA finds no association between neuropsychiatric events and the smoking-cessation medication Chantix.

ICER seeks data on the effectiveness and value of disease modifying therapies for relapsing remitting and primary progressive multiple sclerosis.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

A star-shaped delivery device could prevent medication adherence.

Rates of suicide elevated in cancer survivors diagnosed before the age of 25 years.

Removal of the boxed warning is based on the outcomes of EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), which is a randomized, blinded, active- and placebo-controlled clinical trial, in patients without and with a history of psychiatric disorder.

Managing cancer pain is a challenge for patients and providers alike.

Jury declares Merck’s acquired HCV drug patent valid.

The biosimilar epoetin was well-tolerated in elderly cancer patient populations.

Patients who enrolled in a Health Leads program saw improvements in blood pressure and cholesterol levels.

FDA-approved drug could reduce the risk of death in adults with diabetes and cardiovascular disease.

Xtandi plus abiraterone acetate and prednisone fails to improve progression-free survival in prostate cancer.

Top news of the day from across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.

Jardiance could reduce the risk of death in adults with diabetes and cardiovascular disease.